Logo image
Effect of cimetidine on pharmacokinetics of orally administered cyclosporine in healthy dogs
Journal article   Open access   Peer reviewed

Effect of cimetidine on pharmacokinetics of orally administered cyclosporine in healthy dogs

Jenise Coyne Daigle, Giselle Hosgood, Carol S. Foil and Robert P. Hunter
American journal of veterinary research, Vol.62(7), pp.1046-1050
2001
PMID: 11453478
pdf
Published112.08 kBDownloadView
Published (Version of Record)CC BY-NC V4.0 Open Access

Abstract

Objective To describe the pharmacokinetics of cyclosporine (CyA) in healthy dogs after oral administration alone or in combination with orally administered cimetidine. Animals 10 healthy adult Beagles. Procedure Dogs were randomly assigned to receive CyA alone or CyA in combination with cimetidine. After a washout period of 2 weeks, dogs then received the alternate treatment. The CyA plus cimetidine treatment required administration of cimetidine (15 mg/kg of body weight, PO, q 8 h) for 8 days and administration of CyA (5 mg/kg, PO, q 24 h) on days 6 through 8. The CyA treatment alone required administration of CyA (5 mg/kg, PO, q 24 h) for 3 days. On the third day of CyA administration during each treatment, blood samples were collected immediately before (time 0) and 0.5, 1, 1.5, 2, 2.5, 3, 5, 7, 9, 11, 13, 15, 21, and 24 hours after initiating CyA administration. Results Time until maximum CyA concentration was significantly longer for CyA in combination with cimetidine. Assessment of estimated pharmacokinetic variables revealed a significantly faster rate of change in the distribution phase for CyA in combination with cimetidine. Maximum CyA concentration differed significantly among dogs but did not differ significantly between treatments. Conclusions and Clinical Relevance Analysis of our data suggests that cimetidine may affect absorption of orally administered CyA, but overall, it does not affect the pharmacokinetics of CyA. There is considerable variability in the maximum concentration of CyA among dogs, and monitoring of blood concentrations of CyA during treatment is advised.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

36 File views/ downloads
69 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.157 Organ Donation & Transplantation
1.157.504 Transplant Immunosuppression
Web Of Science research areas
Veterinary Sciences
ESI research areas
Plant & Animal Science
Logo image